Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 151 | 151 | 174 | 142 | 152 |
| Accounts receivable | 7,814 | -10,355 | 62 | 13,104 | -14,026 |
| Other Working Capital | 12,837 | -19,790 | -2,010 | 5,064 | -8,904 |
| Other Operating Activity | -26,908 | 20,531 | -14,821 | -23,323 | 3,740 |
| Operating Cash Flow | $-6,106 | $-9,462 | $-16,595 | $-5,012 | $-19,039 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -85 | 0 | -4 | -23 | 3 |
| Purchase Of Investment | -91 | -49,792 | -1,112 | 849 | N/A |
| Sale Of Investment | N/A | N/A | 1,947 | 23,866 | 20,281 |
| Other Investing Activity | 779 | 514 | 519 | 665 | -26,219 |
| Investing Cash Flow | $603 | $-49,278 | $1,350 | $25,357 | $-5,935 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -123 | 0 | -62 | -56 | -44 |
| Common Stock Issued | 1,452 | 141,537 | 13,519 | 14,605 | 4,060 |
| Other Financing Activity | -15 | -8,263 | 0 | 0 | 0 |
| Financing Cash Flow | $1,314 | $133,274 | $13,457 | $14,548 | $4,016 |
| Exchange Rate Effect | -196 | -15 | -4,088 | 1,637 | -683 |
| Beginning Cash Position | 142,733 | 68,214 | 71,756 | 37,486 | 57,877 |
| End Cash Position | 138,473 | 142,733 | 68,830 | 71,756 | 37,486 |
| Net Cash Flow | $-4,189 | $74,534 | $-1,788 | $34,893 | $-20,957 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,106 | -9,462 | -16,595 | -5,012 | -19,039 |
| Capital Expenditure | N/A | N/A | -4 | -23 | N/A |
| Free Cash Flow | -6,106 | -9,462 | -16,599 | -5,036 | -19,039 |